Andersson B - Search Results

1

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.

Anderlini P, Saliba R, Acholonu S, Okoroji GJ, Donato M, Giralt S, Andersson B, Ueno NT, Khouri I, De Lima M, Hosing C, Cohen A, Ippoliti C, Romaguera J, Rodriguez MA, Pro B, Fayad L, Goy A, Younes A, Champlin RE. Anderlini P, et al. Among authors: andersson b. Bone Marrow Transplant. 2005 May;35(10):943-51. doi: 10.1038/sj.bmt.1704942. Bone Marrow Transplant. 2005. PMID: 15806128

2

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.

Champlin R, Giralt S, Przepiorka D, Ho W, Lee K, Gajewski J, Nimer S, Andersson B, Wallerstein R, Ippolito C, et al. Champlin R, et al. Among authors: andersson b. Prog Clin Biol Res. 1992;377:385-94; discussion 395-8. Prog Clin Biol Res. 1992. PMID: 1438435 No abstract available.

3

Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.

Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, Gajewski J, Khouri I, van Besien K, Andersson B, et al. Ippoliti C, et al. Among authors: andersson b. Urology. 1995 Dec;46(6):811-5. doi: 10.1016/s0090-4295(99)80349-5. Urology. 1995. PMID: 7502421 Clinical Trial.

4

High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.

van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt S, Suki S, Khouri I, et al. van Besien K, et al. Among authors: andersson b. Bone Marrow Transplant. 1995 Apr;15(4):549-55. Bone Marrow Transplant. 1995. PMID: 7655380

5

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.

Giralt S, Escudier S, Kantarjian H, Deisseroth A, Freireich EJ, Andersson BS, O'Brien S, Andreeff M, Fisher H, Cork A, et al. Giralt S, et al. Among authors: andersson bs. N Engl J Med. 1993 Sep 9;329(11):757-61. doi: 10.1056/NEJM199309093291103. N Engl J Med. 1993. PMID: 7688862 Free article.

6

Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Bellare N, Nath R, et al. van Besien KW, et al. Among authors: andersson bs. J Clin Oncol. 1995 May;13(5):1096-102. doi: 10.1200/JCO.1995.13.5.1096. J Clin Oncol. 1995. PMID: 7738615

7

Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.

Körbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, et al. Körbling M, et al. Among authors: andersson b. Blood. 1995 Mar 15;85(6):1659-65. Blood. 1995. PMID: 7888684 Free article.

8

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Andersson B, Khouri I, Giralt S, Rios MB, Champlin R, Hester J, Deisseroth AB. Kantarjian HM, et al. Among authors: andersson b. Bone Marrow Transplant. 1994 Jul;14(1):57-61. Bone Marrow Transplant. 1994. PMID: 7951120 Clinical Trial.

9

A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.

Przepiorka D, Ippoliti C, Giralt S, van Beisen K, Mehra R, Deisseroth AB, Andersson B, Luna M, Cork A, Lee M, et al. Przepiorka D, et al. Among authors: andersson b. Bone Marrow Transplant. 1994 Sep;14(3):449-53. Bone Marrow Transplant. 1994. PMID: 7994271 Clinical Trial.

10

Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.

Przepiorka D, Ippoliti C, Panina A, Goodrich J, Giralt S, van Besien K, Mehra R, Deisseroth AB, Andersson B, Luna M, et al. Przepiorka D, et al. Among authors: andersson b. Bone Marrow Transplant. 1994 Apr;13(4):461-4. Bone Marrow Transplant. 1994. PMID: 8019472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,733 results

Search Page

Filters